docname

aTYR PHARMA INC. LOAN AND SECURITY AGREEMENT (2018-03-20)

THIS THIRD AMENDMENT to Loan and Security Agreement (this "Amendment") is entered into as of December 22, 2017, by and between SILICON VALLEY BANK, a California corporation with an office located at 3003 Tasman Drive, Santa Clara, CA 95054 ("Bank" or "SVB"), as collateral agent (in such capacity, "Collateral Agent"), the Lenders listed on Schedule 1.1 of the Loan Agreement (as defined below) or otherwise party thereto from time to time (each a "Lender" and collectively, the "Lenders") including Bank in its capacity as a Lender and SOLAR CAPITAL LTD., a Maryland corporation with an office located at 500 Park Avenue, 3rd Floor, New York, New York 10022 ( "Solar") and ATYR PHARMA, INC., a Delaware corporation with offices located at 3545 John Hopkins Court, Suite 250, San Diego, CA 92121 ("Borrower").

aTYR PHARMA INC. Transition and Separation Agreement (2018-03-20)

this Agreement does not become effective. You acknowledge and agree that upon your receipt of the Severance Benefits, you will have no further rights under the Severance Policy.

aTYR PHARMA INC. LOAN AND SECURITY AGREEMENT (2018-03-20)

THIS SECOND AMENDMENT to Loan and Security Agreement (this "Amendment") is entered into as of October 10, 2017, by and between SILICON VALLEY BANK, a California corporation with an office located at 3003 Tasman Drive, Santa Clara, CA 95054 ("Bank" or "SVB"), as collateral agent (in such capacity, "Collateral Agent"), the Lenders listed on Schedule 1.1 of the Loan Agreement (as defined below) or otherwise party thereto from time to time (each a "Lender" and collectively, the "Lenders") including Bank in its capacity as a Lender and SOLAR CAPITAL LTD., a Maryland corporation with an office located at 500 Park Avenue, 3rd Floor, New York, New York 10022 ( "Solar") and ATYR PHARMA, INC., a Delaware corporation with offices located at 3545 John Hopkins Court, Suite 250, San Diego, CA 92121 ("Borrower").

Zendesk, Inc.. The purpose of this communication (this ?Confirmation?) is to set forth the term (2018-03-20)

This Confirmation evidences a complete and binding agreement between Dealer and Counterparty as to the terms of the Transaction to which this Confirmation relates. This Confirmation shall be subject to an agreement (the “ **Agreement** ”) in the form of the 2002 ISDA Master Agreement as if Dealer and Counterparty had executed an agreement in such form on the date hereof (but without any Schedule except for (i) the election of US Dollars (“ **USD** ”) as the Termination Currency, (ii) the election of the laws of the State of New York as the governing law (without reference to choice of law doctrine), )[, (iii) the election of an executed guarantee of [__________] (“ **Guarantor** ”) dated as of the Trade Date in customary form as a Credit Support Document, (iv) the election of Guarantor as Credit Support Provider in relation to Dealer]20 and [v][(iii)](A) the election that the “Cross Default” provisions of Section 5(a)(vi) of the Agreement shall apply to Dealer with a “Threshold Amount” of three percent of Dealer’s parent’s shareholders’ equity; _provided_ that “Specified Indebtedness” shall not include obligations in respect of deposits received in the ordinary course of Dealer’s banking business, (B) the phrase “or becoming capable at such time of being declared” shall be deleted from clause (1) of such Section 5(a)(vi) and (C) the following language shall be added to the end thereof “Notwithstanding the foregoing, a default under subsection (2) hereof shall not constitute an Event of Default if (x) the default was caused solely by error or omission of an administrative or operational nature; (y) funds were available to enable the party to make the payment when due; and (z) the payment is made within two Local Business Days of such party’s receipt of written notice of its failure to pay.”).

Zander Therapeutics, Inc. SECURITIES PURCHASE AGREEMENT (2018-03-20)

THIS SECURITIES PURCHASE AGREEMENT (the "Agreement") is entered into by and among Zander Therapeutics, Inc., a Nevada corporation (the "Company") whose address is 4700 Spring Street, St 304, La Mesa, California 91942 and MBRG Investors LLC( "Purchaser"), a California Limited Liability Company whose address is 9200 Sunset Boulevard, Suite 555 West Hollywood, CA .

Zander Therapeutics, Inc. SECURITIES PURCHASE AGREEMENT (2018-03-20)

THIS SECURITIES PURCHASE AGREEMENT (the "Agreement") is entered into by and among Zander Therapeutics, Inc., a Nevada corporation (the "Company") whose address is 4700 Spring Street, St 304, La Mesa, California 91942 and Hall Family Trust dated 7/21/2003 ("Purchaser") a person whose address is 5019 Tierra Del Oro Carlsbad CA.

Zander Therapeutics, Inc. SECURITIES PURCHASE AGREEMENT (2018-03-20)

THIS SECURITIES PURCHASE AGREEMENT (the "Agreement") is entered into by and among Zander Therapeutics, Inc., a Nevada corporation (the "Company") whose address is 4700 Spring Street, St 304, La Mesa, California 91942 and the Lloyd Eric Cotson Trust ( a California Revocable Trust as amended and completely restated June 8, 2016) whose address is 1880 Veteran Ave, Suit #310, Los Angeles CA .

Zander Therapeutics, Inc. License Agreement (2018-03-20)

theMaven, Inc.. AGREEMENT (2018-03-19)

iHeartMedia, Inc.. RESTRUCTURING SUPPORT AGREEMENT (2018-03-19)

THIS RESTRUCTURING SUPPORT AGREEMENT IS NOT AN OFFER OR ACCEPTANCE WITH RESPECT TO ANY SECURITIES OR A SOLICITATION OF ACCEPTANCES OF A CHAPTER 11 PLAN WITHIN THE MEANING OF SECTION 1125 OF THE BANKRUPTCY CODE. ANY SUCH OFFER OR SOLICITATION WILL COMPLY WITH ALL APPLICABLE SECURITIES LAWS AND/OR PROVISIONS OF THE BANKRUPTCY CODE. NOTHING CONTAINED IN THIS RESTRUCTURING SUPPORT AGREEMENT SHALL BE AN ADMISSION OF FACT OR LIABILITY OR, UNTIL THE OCCURRENCE OF THE AGREEMENT EFFECTIVE DATE ON THE TERMS DESCRIBED HEREIN, DEEMED BINDING ON ANY OF THE PARTIES HERETO.

Google Adsense

more

Total filling count: 1653925